Wells Fargo & Company Amphastar Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 23,552 shares of AMPH stock, worth $730,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,552

Previous 42,688 44.83%

Holding current value

$730,583

Previous $2.07 Million 57.8%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$36.84 - $53.4 $704,970 - $1.02 Million	-19,136 Reduced 44.83%	23,552 $874,000
Q3 2024 Nov 13, 2024	SELL	$36.99 - $50.09 $1.08 Million - $1.46 Million	-29,098 Reduced 40.53%	42,688 $2.07 Million
Q2 2024 Aug 13, 2024	BUY	$38.65 - $43.48 $562,164 - $632,416	14,545 Added 25.41%	71,786 $2.87 Million
Q1 2024 May 10, 2024	BUY	$42.85 - $63.45 $881,810 - $1.31 Million	20,579 Added 56.13%	57,241 $2.51 Million
Q4 2023 Feb 09, 2024	BUY	$44.49 - $62.93 $375,451 - $531,066	8,439 Added 29.9%	36,662 $2.27 Million
Q3 2023 Nov 13, 2023	SELL	$45.51 - $65.0 $376,322 - $537,485	-8,269 Reduced 22.66%	28,223 $1.3 Million
Q2 2023 Aug 15, 2023	BUY	$35.77 - $58.38 $693,973 - $1.13 Million	19,401 Added 113.52%	36,492 $2.1 Million
Q1 2023 May 12, 2023	BUY	$27.99 - $37.92 $380,020 - $514,839	13,577 Added 386.37%	17,091 $640,000
Q4 2022 Feb 13, 2023	SELL	$27.93 - $31.27 $37,621 - $42,120	-1,347 Reduced 27.71%	3,514 $98,000
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $387,796 - $531,180	-14,071 Reduced 74.32%	4,861 $137,000
Q2 2022 Aug 12, 2022	SELL	$29.79 - $42.29 $1.84 Million - $2.61 Million	-61,753 Reduced 76.54%	18,932 $659,000
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $191,670 - $304,284	8,348 Added 11.54%	80,685 $2.9 Million
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $4.41 Million - $5.67 Million	-243,292 Reduced 77.08%	72,337 $1.69 Million
Q3 2021 Nov 15, 2021	SELL	$17.83 - $21.49 $934,113 - $1.13 Million	-52,390 Reduced 14.24%	315,629 $6 Million
Q2 2021 Aug 16, 2021	BUY	$17.11 - $20.92 $3.18 Million - $3.88 Million	185,684 Added 101.84%	368,019 $7.42 Million
Q1 2021 May 13, 2021	BUY	$17.21 - $20.65 $44,728 - $53,669	2,599 Added 1.45%	182,335 $3.34 Million
Q4 2020 Feb 09, 2021	SELL	$17.76 - $21.24 $520,439 - $622,416	-29,304 Reduced 14.02%	179,736 $3.62 Million
Q3 2020 Nov 05, 2020	SELL	$17.99 - $22.22 $443,813 - $548,167	-24,670 Reduced 10.56%	209,040 $3.92 Million
Q2 2020 Aug 13, 2020	BUY	$14.25 - $22.46 $1.9 Million - $3 Million	133,618 Added 133.5%	233,710 $5.25 Million
Q1 2020 May 14, 2020	BUY	$12.66 - $20.08 $1.27 Million - $2.01 Million	100,092 New	100,092 $1.49 Million

Others Institutions Holding AMPH

# of Institutions

275

Shares Held

35.1M

Call Options Held

56.2K

Put Options Held

3.5K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.52B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Amphastar Pharmaceuticals, Inc. Transaction History